COVID-19: Concerns over increased load of residual antibiotics in wastewater

  02 September 2020

The use of antibiotics during the novel coronavirus disease (COVID-19) and its linkages with antimicrobial resistance (AMR) have earlier been talked about. Antibiotics are being employed — mostly in hospital or intensive care unit settings — to prevent secondary bacterial infections (co-infections) along with the viral infection caused by the SARS-CoV-2 virus that causes COVID-19.

Studies showed while the prevalence of bacterial infections was low in COVID-19 patients, a majority of them were administered with antibiotics, including broad spectrum ones. This was often done as part of empiric therapy, in the absence of appropriate bacterial characterisation or antibiotic susceptibility testing.

In parallel, there were emerging concerns over implications of such high levels of antibiotic use on the environment.

Further reading: DownToEarth
Author(s): Rajeshwari Sinha
Clean Environment  

Registration now open:

International Masterclass AMR 29 SEP delivered digitally: 2 = 1!


  • Science, Health-Economic & Societal impact
  • Global causes and global solutions
  • Bottom-up, interactive approach
  • International Experts involved

Offered online!

Register today >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!